Senior Director, Vonjo, Core Asset Team (CAT) Lead

📋 Description

• Define and lead the global asset strategy for Vonjo, aligned with corporate priorities, spanning
• Develop and maintain a high-quality Integrated Project Plan (IPP), including resourcing and budget.
• Drive lifecycle management (LCM) to extend product value and optimize portfolio performance, with a
• Lead the strategic development of the new VEXAS indication, including shaping the global program
• Ensure readiness of global regulatory submissions and approvals for myelofibrosis label expansion
• Align evidence generation plans with asset strategy, guiding clinical, medical, and real-world data

🎯 Requirements

• Master's degree in a relevant field (science background strongly preferred).
• 10+ years in global biopharma leadership, ideally in hematology and/or rheumatology.
• Proven track record in lifecycle management, global asset strategy, and launch leadership.
• Strong cross-functional leadership and stakeholder management skills.
• Strategic thinker with disciplined execution and sound business judgment.
• Skilled communicator and influencer across senior levels.

🎁 Benefits

• Competitive compensation for your work
• Generous time off policy
• Opportunity to broaden your horizons by attending popular conferences
• Emphasis on work/life balance
• Collaborative and team-oriented environment
• Making a positive impact to help ultra-rare disease patients who are in need of life saving